Vice Chairman, Chief Commercial Officer · AbbVie Inc. (ABBV)

Carlos Alban

A named executive officer of AbbVie in every fiscal year CompBrief holds from FY2016 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$16,853,926

Salary $1,211,808Stock awards $5,822,401

FY2019: $14,406,090

3rd of 5 named executive officers at AbbVie by FY2020 total.

5 named officers on file for AbbVie, FY2020

Carlos Alban’s pay file — $29

  • 5 fiscal years of pay, line by line
  • 9 equity grants, each cited to its filing
  • ABBV’s disclosed peer group of 9 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how AbbVie’s whole pay program stands against its peers

  • AbbVie’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ABBV→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 22, 2021 (DEF 14A).

Free

Get Carlos Alban’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Carlos Alban compensation by year

AbbVie Summary Compensation Table · all 5 fiscal years held
In US dollars, as AbbVie reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019FY2020
Salary$920,077$947,469$1,016,526$1,176,538$1,211,808
Bonus$0$0$0$0$0
Stock awards$2,916,922$3,522,250$4,005,388$3,091,161$5,822,401
Option awards$738,798$938,350$961,216$781,305$1,390,831
Non-equity incentive$1,510,000$1,836,219$1,836,219$2,400,000$2,475,000
Pension and deferred compensation$1,884,312$4,832,949$821,930$6,456,803$5,629,242
All other$246,809$257,751$341,800$500,283$324,644
Total$8,216,918$12,334,988$8,983,079$14,406,090$16,853,926

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: AbbVie Inc. DEF 14A filed March 22, 2021, accession 0001558370-21-003318, and prior-year filings. Open the filing on EDGAR.

How this page was built: the AbbVie Inc. filed document, accession 0001558370-21-003318. Every figure is read from that document and cited to the page and table it appears in. Filed March 22, 2021.

$8.2M
$12.3M
$9.0M
$14.4M
$16.9M
FY16
FY17
FY18
FY19
FY20
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
PSU59,892$6,417,428—
PSU33,746$3,615,884—
PSU21,907$2,347,335—
Option114,566—$93.50
Option41,536—$79.02
Option14,810—$114.36

Per the Outstanding Equity Awards at Fiscal Year-End table in AbbVie Inc.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.

AbbVie’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Richard GonzalezChairman of the Board and Chief Executive Officer$24,007,591
Laura SchumacherVice Chairman, External Affairs and Chief Legal Officer$17,126,276
Carlos Alban · this pageVice Chairman, Chief Commercial Officer$16,853,926
Robert MichaelExecutive Vice President, Chief Financial Officer$13,494,629
Michael SeverinoVice Chairman and President$13,411,058

The full AbbVie compensation record

free company brief

This page is one person within AbbVie's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the AbbVie proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are AbbVie's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Carlos Alban's compensation dossier · One-time report. No refunds.